ALZAMEND NEURO, INC.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Apr 2019 | — | — | $42.6K |
| Apr 2020 | $992.3K | $1.8M | $90.3K |
| Jul 2020 | — | — | $63.1K |
| Oct 2020 | — | — | $5.9K |
| Jan 2021 | — | — | $40.7K |
| Apr 2021 | $899.6K | $2.9M | $1.9M |
| Jul 2021 | $1.5M | $16.8M | $15.6M |
| Oct 2021 | $1.5M | $14.5M | $13.6M |
| Jan 2022 | $467.0K | $12.4M | $11.8M |
| Apr 2022 | $1.2M | $14.5M | $14.1M |
| Jul 2022 | $1.0M | $12.2M | $11.5M |
| Oct 2022 | $1.6M | $10.4M | $9.2M |
| Jan 2023 | $2.6M | $8.5M | $7.4M |
| Apr 2023 | $2.9M | $5.9M | $5.1M |
| Jul 2023 | $2.7M | $2.6M | $1.7M |
| Oct 2023 | $3.7M | $983.6K | $200.1K |
| Jan 2024 | $4.6M | $782.6K | $282.9K |
| Apr 2024 | $3.2M | $631.6K | $376.0K |
| Jul 2024 | $2.9M | $1.7M | $1.2M |
| Oct 2024 | $1.3M | $5.0M | $4.1M |
| Jan 2025 | $725.9K | $4.2M | $3.4M |
| Apr 2025 | $634.8K | $4.6M | $3.9M |
| Jul 2025 | $983.3K | $6.3M | $5.6M |
| Oct 2025 | $717.5K | $5.1M | $4.4M |
| Jan 2026 | $1.9M | $4.0M | $2.7M |
| Apr 2026 | $1.3M | $2.1M | $710.7K |
| Jul 2026 | $2.7M | $8.5M | $7.6M |